Eurofarma Executive and Leadership Team

Eu Tu, the Chief Executive Officer at Eurofarma, directs the company's overall strategic vision and operational execution. This leadership role involves guiding Eurofarma's diverse product portfolio, which spans prescription medications, generics, oncology treatments, hospital care, personal care, and nutritional supplements. Tu ensures alignment across all business units, fostering an environment of continuous innovation and clinical research and development. The Chief Executive Officer's responsibilities extend to maintaining Eurofarma's strong corporate governance framework and driving its commitment to sustainability. By overseeing the company's expansion and market penetration across Latin America, Eu Tu solidifies Eurofarma's position as a key player in improving health and wellness for healthcare professionals, consumers, pharmacies, and B2B clients. This executive's focus is on long-term growth and enhancing the company's impact within the pharmaceutical sector.

Maurizio Billi, the Global Chief Executive Officer at Eurofarma, spearheads the company's international expansion and strategic global initiatives. Billi's leadership encompasses driving the company's mission to improve health and wellness across diverse markets in Latin America and beyond. This role involves overseeing the development and execution of strategies for Eurofarma's broad product range, including prescription medications, generics, oncology treatments, and hospital care products. The Global Chief Executive Officer ensures that Eurofarma's commitment to sustainability and innovation is integrated into all international operations. Maurizio Billi's oversight extends to fostering robust relationships with healthcare professionals, consumers, pharmacies, and B2B clients, thereby strengthening the company's market presence. By championing clinical research and development, Billi positions Eurofarma for sustained growth and leadership in the global pharmaceutical industry.

Bruna Sudo, the Chief Marketing Officer, International Business Development at Eurofarma, architects the global marketing strategies and drives international business expansion. Sudo's responsibilities include identifying new market opportunities and developing tailored approaches for Eurofarma's diverse product lines, encompassing prescription medications, generics, oncology treatments, and personal care items. The Chief Marketing Officer, International Business Development oversees the promotion of Eurofarma's commitment to sustainability and innovation across international territories. Bruna Sudo ensures that marketing efforts effectively reach healthcare professionals, consumers, pharmacies, and B2B clients, enhancing brand visibility and market penetration. This leadership position involves close collaboration with regional teams to adapt strategies to local market needs, thereby supporting the company's overarching mission to improve health and wellness. Sudo's strategic direction is crucial for Eurofarma's sustained growth in the competitive pharmaceutical landscape.

Fernando Da, the Head Chief Marketing Officer, International Business at Eurofarma, directs the strategic marketing initiatives and business development efforts for international markets. Da's role focuses on expanding Eurofarma's reach with its comprehensive product offerings, including prescription medications, generics, oncology treatments, and hospital care products. The Head Chief Marketing Officer, International Business ensures that the company's dedication to sustainability and innovation resonates with target audiences across Latin America. Fernando Da oversees the implementation of marketing campaigns designed to engage healthcare professionals, consumers, pharmacies, and B2B clients, thereby strengthening Eurofarma's brand presence and market share. This executive's leadership is vital in navigating the complexities of international business development and supporting the company's core mission of improving health and wellness. Da's strategic insights drive profitable growth and solidify Eurofarma's position as a leading pharmaceutical entity.